tiprankstipranks
Trending News
More News >
Lotus Bio-Technology Development Corp. (LBTD)
OTHER OTC:LBTD
US Market

Lotus Bio-Technology Development (LBTD) Financial Statements

Compare
8 Followers

Lotus Bio-Technology Development Financial Overview

Lotus Bio-Technology Development's market cap is currently $783.00. The company's EPS TTM is $; its P/E ratio is ―; Lotus Bio-Technology Development is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 17
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income$ -19.55K
EBITDA$ -19.55K
Net Income$ -19.55K
Balance Sheet
Cash & Short-Term Investments$ 0.00
Total Assets$ 0.00
Total Debt$ 6.45K
Net Debt$ 6.45K
Total Liabilities$ 80.86K
Stockholders' Equity$ -61.31K
Cash Flow
Free Cash Flow$ -17.75K
Operating Cash Flow$ -17.75K
Investing Cash Flow$ 0.00
Financing Cash Flow$ 17.75K
Currency in USD

Lotus Bio-Technology Development Earnings and Revenue History

Lotus Bio-Technology Development Debt to Assets

Lotus Bio-Technology Development Cash Flow

Lotus Bio-Technology Development Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.